1314 E LAS OLAS BLVD, SUITE 221, FORT LAUDERDALE, FL
Employment Agreements with Brady Cobb and Michael Bondurant Signed
Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program
To Become Endovia Health Sciences; New NYSE American Ticker 'EDVA' Effective Monday
Reports Second Quarter 2026 Results and Highlights Strategic Transformation Toward Endovia Health Sciences
To Rebrand as Endovia Health Sciences
Name Change to Endovia Health Sciences, Inc. Filed by Splash Beverage Group
Partners with Veteran Cannabinoid Drug-Development Team to Advance CannEpil® through FDA Veterinary Pathway
Amended material disclosure
Q2
Notice of Late Filing for Quarterly Report
Q1
Amended Annual Report
FY 2025
Notice of Late Filing for Annual Report
Q3
Effectiveness Notice
Amended Registration Statement for Securities
S-1
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
PRER14A
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Submission Upload
Correspondence